MORGAN STANLEY PLC/CALL/AMGEN/320/0.1/17.01.25 | Market Closed - Börse Stuttgart 14:46:03 2024-07-03 EDT | ||
| 2.24 EUR | -6.28% |
|
| Current month | -8.57% | ||
| 1 month | -5.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 2.24 | -6.28% |
| 24-07-02 | 2.39 | +0.42% |
| 24-07-01 | 2.38 | -2.86% |
| 24-06-28 | 2.45 | +0.41% |
| 24-06-27 | 2.44 | -5.43% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 02:46 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MB0BQE |
| ISIN | DE000MB0BQE8 |
| Date issued | 2022-11-09 |
| Strike | 320 $ |
| Maturity | 2025-01-17 (198 Days) |
| Parity | 10 : 1 |
| Emission price | 3.94 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.04 € |
|---|---|
| Lowest since issue | 0.37 € |
| Delta | 0.5x |
| Omega | 6.346 |
| Premium | 11.38x |
| Gearing | 12.58x |
| Moneyness | 0.9668 |
| Difference Strike | 10.62 $ |
| Difference Strike % | +3.32% |
| Spread | 0.08 € |
| Spread % | 3.45% |
| Theoretical value | 2.280 |
| Implied Volatility | 30.27 % |
| Total Loss Probability | 57.68 % |
| Intrinsic value | 0.000000 |
| Present value | 2.280 |
| Break even | 344.59 € |
| Theta | -0.05x |
| Vega | 0.08x |
| Rho | 0.07x |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.4
USD
Spread / Average Target
+2.28%
- Stock Market
- Warrants
- Warrant
